| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 10/17/2001 | CN1318063A Process for obtaiing HMG-CoA reductase inhibitors of high purity |
| 10/17/2001 | CN1073119C Method and compsns. for dry powder formulation of interferons |
| 10/17/2001 | CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof |
| 10/16/2001 | US6303340 Isolating preferential fusion protein; express fusion protein in cell, recover inclusion bodies, split fusion protein, solubilize split products, isolate protein |
| 10/16/2001 | US6303322 Testing in multiplicity of wells; generating thermal unfolding or denaturation curve; combinatorial chemistry; receptor binding assay |
| 10/16/2001 | US6303287 Evaluating binding activity of particles to preferential protein domains; mix binding domain and chemical particles |
| 10/16/2001 | US6303126 Treatment of fibrosis by HGF |
| 10/16/2001 | US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group. |
| 10/16/2001 | CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein |
| 10/16/2001 | CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 10/11/2001 | WO2001075435A2 Fluorescence assay for gamma-secretase activity and inhibitors |
| 10/11/2001 | WO2001075432A2 A method and device for analysis of charged molecules by solution isoelectric focusing |
| 10/11/2001 | WO2001074844A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | WO2001074843A1 Process for preparing coagulants for water treatment |
| 10/11/2001 | WO2001074842A1 Macromolecule detection |
| 10/11/2001 | WO2001074130A2 A computer based method for identifying conserved invariant peptide motifs |
| 10/11/2001 | WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 10/11/2001 | US20010029018 Deparaffinizing tissue sample, rehydrating, heating and homogenizing in chaotropic agent (guanidine thiocyanate), recovering RNA and converting to cDNA by reverse tran-scription, then polymerase chain reaction with fluorescent dye |
| 10/11/2001 | US20010028866 Chemical synthesis apparatus employing a droplet generator |
| 10/11/2001 | CA2405332A1 Fluorescence assay for gamma-secretase activity and inhibitors |
| 10/11/2001 | CA2402416A1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | CA2376710A1 A computer based method for identifying conserved invariant peptide motifs |
| 10/10/2001 | EP1143009A1 Process for producing polypeptide in cell-free protein synthesis system |
| 10/10/2001 | EP1143006A2 Vectors/DNA-sequences from human combinatorial antibody libraries |
| 10/10/2001 | EP1142904A1 Sponge protein hydrolysates and methods of producing the same |
| 10/10/2001 | EP1142484A2 Isolation of lactoferrin from milk |
| 10/10/2001 | EP1141375A1 Metallopeptide combinatorial libraries and applications |
| 10/10/2001 | EP1141250A2 Intein-mediated cyclization of peptides |
| 10/10/2001 | EP1141137A1 Water-soluble rhodamine dyes and conjugates thereof |
| 10/10/2001 | EP1141022A1 Serine protease inhibitor |
| 10/10/2001 | EP1140981A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 10/10/2001 | EP1140978A1 Methods of identifying antigen gene sequences |
| 10/10/2001 | EP1140977A2 Method and devices for applying substances to a support, especially monomers for the combinatorial synthesis of molecule libraries |
| 10/10/2001 | EP1140316A1 Continuous method for separating substances according to molecular size |
| 10/10/2001 | EP1140214A1 Removal of biological contaminants |
| 10/10/2001 | EP0830372B1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
| 10/10/2001 | CN1317011A Process for couping amino acids using bis-(trichloromethyl) carbonate |
| 10/10/2001 | CN1316430A In-line chromatographic docking process for protein disulfide bonds |
| 10/09/2001 | US6300119 Stretococcal ERS |
| 10/09/2001 | US6300103 A protein isolated from sugar beets; fungicides, viricides, herbicide resistance, nematode resistance, bacteriocides |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300099 Methods for producing secreted ligand-binding fusion proteins |
| 10/09/2001 | US6300079 Polypeptide and process for measuring living body components using the same |
| 10/09/2001 | US6300064 Protein/(poly)peptide libraries |
| 10/09/2001 | CA2222296C Peptide and method of obtaining it |
| 10/04/2001 | WO2001073125A2 High throughput screening array containing porous material |
| 10/04/2001 | WO2001072844A2 A METHOD OF PRODUCING IgG |
| 10/04/2001 | WO2001072779A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/04/2001 | WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | WO2001072769A2 Methods for purifying highly anionic proteins |
| 10/04/2001 | WO2001072412A1 Method and device for investigating substance libraries |
| 10/04/2001 | WO2001072411A1 Reaction device for organic synthesis |
| 10/04/2001 | WO2001072329A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof |
| 10/04/2001 | WO2000035941A3 Combinatorial process for preparing polyamines |
| 10/04/2001 | US20010026935 First and second column select transistors, the column select transistors being adapted for control by column selector, first and second row select transistors, being adapted for control by row selector, output connected to node |
| 10/04/2001 | US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets |
| 10/04/2001 | US20010026778 Systems and methods for the active electronic control of biological reactions |
| 10/04/2001 | EP1144434A3 Combinatorial process for preparing polyamines |
| 10/04/2001 | EP1138691A1 Method for improving solubility of protein |
| 10/04/2001 | EP1137941A1 Protein scaffolds for antibody mimics and other binding proteins |
| 10/04/2001 | EP1137797A1 Expression system for factor viii |
| 10/04/2001 | EP1137690A2 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 10/04/2001 | EP1137663A2 Purification of echinocandin cyclopeptide compounds |
| 10/04/2001 | EP1137661A1 Procollagen c-proteinase inhibitors |
| 10/04/2001 | EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 10/04/2001 | EP1137442A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 10/04/2001 | EP1086119A4 Purification of antibodies |
| 10/04/2001 | DE10015391A1 Capillary plate for investigating the molecular interaction of active agents with immobilized peptides |
| 10/04/2001 | CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/04/2001 | CA2404164A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | CA2402784A1 A method of producing igg |
| 10/04/2001 | CA2402780A1 Insulin and igf-1 receptor agonists and antagonists |
| 10/03/2001 | CN1315999A Genetic method for expression of polyproteins in plants |
| 10/03/2001 | CN1315966A High-affinity antibodies |
| 10/03/2001 | CN1315965A Hepatitis C inhibitor peptides |
| 10/03/2001 | CN1315964A Protein/polypeptide-K obtained from i(momordica charantia) and process for extraction thereof |
| 10/03/2001 | CN1315328A Protein resisting against plant mosaic virus |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6296673 Methods and apparatus for performing array microcrystallizations |
| 10/02/2001 | CA2210987C Chromatographic purification of vancomycin hydrochloride by the use of preparative hplc |
| 10/02/2001 | CA2148223C Bacteriocins from streptococcus thermophilus |
| 10/02/2001 | CA2041268C Peptides with a bradykinin-antagonistic action |
| 10/02/2001 | CA2001720C Membrane affinity apparatus and purification methods related thereto |
| 09/27/2001 | WO2001071732A2 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 09/27/2001 | WO2001071359A2 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 09/27/2001 | WO2001071346A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/27/2001 | WO2001070772A2 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid |
| 09/27/2001 | WO2001070768A2 Receptor-binding compounds and method for identifying them |
| 09/27/2001 | WO2001070765A1 Receptor-binding compounds and methods for identifying them |
| 09/27/2001 | WO2001070761A1 Uses of alkylammonium salts in protein renaturation |
| 09/27/2001 | WO2001070730A1 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
| 09/27/2001 | WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | WO2001070275A2 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 09/27/2001 | WO2001000665A3 Inhibitors of memapsin 2 and use thereof |
| 09/27/2001 | CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 09/27/2001 | CA2684455A1 Method and apparatus for processing substances in a single container |
| 09/27/2001 | CA2409333A1 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 09/27/2001 | CA2404139A1 Binding compounds and methods for identifying binding compounds |
| 09/27/2001 | CA2403803A1 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid |